Cross-sectional baseline analysis of electrocardiography in a large cohort of patients with untreated Fabry disease

Electrocardiographic changes in early recognition of Fabry disease

(2011) M. Namdar et al.   HEART

Differences in Fabry Cardiomyopathy Between Female and Male Patients

(2011) Markus Niemann et al.   JACC-Cardiovascular Imaging

PQ Interval in Patients With Fabry Disease

(2010) Mehdi Namdar et al.   AMERICAN JOURNAL OF CARDIOLOGY

The right ventricle in Fabry disease: natural history and impact of enzyme replacement therapy

(2010) M. Niemann et al.   HEART

Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy

(2009) Frank Weidemann et al.   CIRCULATION

A 4-year study of the efficacy and tolerability of enzyme replacement therapy with agalsidase alfa in 36 women with Fabry disease

(2009) Catharina Whybra et al.   GENETICS IN MEDICINE

Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey

(2009) A Mehta et al.   JOURNAL OF MEDICAL GENETICS

Age and gender specific normal values of left ventricular mass, volume and function for gradient echo magnetic resonance imaging: a cross sectional study

(2009) Peter A Cain et al.   BMC MEDICAL IMAGING

Angina in Fabry Disease Reflects Coronary Small Vessel Disease

(2008) Cristina Chimenti et al.   Circulation-Heart Failure

Effects of enzyme replacement therapy on the cardiomyopathy of Anderson Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa

(2007) D A Hughes et al.   HEART